Jeffrey S. Poulter, M.D., a board-certified plastic surgeon, has successfully completed surgery using the recently approved Natrelle®410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implant by Allergan, Inc. These specially shaped gel implants provide an important new alternative to traditional round implants for women considering breast reconstruction or augmentation. “Using this highly cohesive gel implant provided a superior result in my patient who had little upper pole fullness there,” says Dr. Jeffrey Poulter, following his first surgery using the new implants.
“The Natrelle®410 is the most selected shaped gel implant in markets where the product is already available such as Europe and Canada,” said David E. I. Pyiott, Allergan’s Chairman of the Board, President and Chief Executive Officer. “We are pleased that the FDA has recognized the benefits and safety of the Natrelle®410, and has now made the product available as an additional option for women in the United States.”
The FDA approval of the Natrelle® 410 was based on an extensive review of various studies and data, including pre-clinical device testing and clinical data from Allergan’s 10-year prospective, multi-center pivotal study, involving nearly 1,000 women who have undergone breast surgery.
Dr. Poulter uses his past experience with shaped saline implants and combines it with his recent completion of required training with Allergan to optimize the use of Natrelle® 410 implant. Dr. Poulter’s early adoption of the new implant technology will harness the significant benefits these new implants offer. Gel implants have been available for breast reconstruction since 2000 and for augmentation since 2006. Breast implants are the most studied implantable device known to man after device placement was limited in 1992.
Jeffrey S. Poulter is a board-certified plastic surgeon with over 22 years of experience and 20,000 patients. For more information, request a consultation, call (309) 663-1222 or visit www.drpoulter.com